In 2018, we dramatically advanced our mission to bring computer-aided-design to scientific experimentation.
Our favorite moment was the day one customer said we saved 2400 hours per year of wasted time in their four-person assay workflow. That's what we mean by "Lab data to machine learning in 30 seconds."
Riffyn Nexus (Riffyn SDE) has expanded its deployments to multiple Fortune 100 companies in biopharmaceuticals, industrial biotech and materials science, while still serving small and mid-sized companies with the exact same capabilities and scientific insights.
We also extended our platform to serve the entire scientific product lifecycle, including DNA assembly, strain engineering, tissue engineering, analytical chemistry, microtiter-based screening, bioassays, enzymology, material characterization, cell culture, fermentation, downstream processing, product formulations, toxicology and tech transfer. You can watch some of these case studies on our website.
If you have a minute, take a peak at our latest peer-reviewed article on re-thinking the way we conduct and communicate science with 'blueprints for science', and see a few highlights from 2018 below.
We wish you a very happy and successful new year!
Highlights from 2018
Granted our first US patent for Riffyn Nexus (Riffyn SDE)
Five major product releases including an upgrade to full 21 CFR 11 compliance and GxP readiness, an AddIn for JMP, and data connectors for OSI Pi Server, Spotfire and Tableau and many upgrades to our powerful REST API
Launched Riffyn Open Access for researchers at non-profit institutions
At Riffyn, we take pride in the fact that we are a scientific partner with our customers, not simply a vendor. We are a dedicated, dynamic group of people passionate about helping our customers discover more.